Gefurulimab and Generalized Myasthenia Gravis

JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association

Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Effica...View more